TITLE

ASSESSMENT OF MC1R AND α-MSH GENE SEQUENCES IN IRANIAN VITILIGO PATIENTS

AUTHOR(S)
Eskandani, M.; Hasannia, S.; Vandghanooni, S.; Pirooznia, N.; Golchai, J.
PUB. DATE
October 2010
SOURCE
Indian Journal of Dermatology;Oct-Dec2010, Vol. 55 Issue 4, p325
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Vitiligo is an acquired pigmentary disorder of the skin that is caused by unknown factors and is characterized by white and depigmented patches that enlarge and become more numerous with time. Genetic factors, oxidative stress, autoimmunity, and neurochemical agents, such as catecholamines might also contribute to vitiligo. Cutaneous pigmentation is determined by the amounts of eumelanin and pheomelanin synthesized by the epidermal melanocytes and interference of melanocortin-1 receptor (MC1R), a G-protein coupled receptor, its normal agonist, alphamelanocyte stimulating hormone (á-MSH), and key enzymes, such as tyrosinase, to protect against sun-induced DNA damage. The MC1R, a 7 pass trans-membrane G-protein coupled receptor, is a key control point in melanogenesis. Lossof- function mutations at the MC1R are associated with a switch from eumelanin to pheomelanin production, resulting in a red or yellow coat color. Aim: In this research, we aim to examine the genetic variety of MC1R and á-MSH gene in 20 Iranian vitiligo patients and 20 healthy controls. Materials and Methods: Analysis of the MC1R coding gene was performed with direct sequencing. Results: We found the following 9 MC1R coding region variants: Arg163Gl (G488A), Arg227Leu (G680A), Val 97Phe (G289T), Asp184Asn (G550A), Arg227Lys (G680A), Arg142His (G425A), Val60Leu (G178T), Val247Met (C739A), and Val174Ile (G520A). We also found 2 frameshift changes: one of them was the Insertion of C (frameshift in Pro136, stop at Trp148) and the other, Insertion of G (frameshift in Pro256, stop at Trp 333). Of all the changes, the most common was Val60Leu at 5% in patients vs 20% in controls, Val247Met at 15% in patients vs 0% in controls and Val174Ile at 15% in controls and 0% in patients. The other variants showed a frequency <5% in both patients and controls. Also in this study, we have examined the frequency of single nucleotide polymorphisms within the á-MSH genes with direct sequencing in 20 patients and 20 healthy subjects but found no changes along this gene. Conclusion: We could not find any relationship between MC1R and á-MSH genes and their effect on the disease in Iranian vitiligo patients.
ACCESSION #
57270721

 

Related Articles

  • Lack of association with TNF-α-308 promoter polymorphism in patients with vitiligo. Yazici, Ayca Cordan; Erdal, M. Emin; Kaya, Tamer Irfan; Ikizoglu, Guliz; Savasoglu, Kaan; Camdeviren, Handan; Tursen, Umit // Archives of Dermatological Research;Jun2006, Vol. 298 Issue 1, p46 

    Vitiligo is an acquired depigmentary disorder of the skin, characterized by incomplete penetrance, multiple susceptibility loci and genetic heterogeneity. An immunologic hypothesis is currently advanced as a possible pathogenesis of vitiligo. The cytokines have an important role in pathogenesis...

  • Transcriptional Analysis of Vitiligo Skin Reveals the Alteration of WNT Pathway: A Promising Target for Repigmenting Vitiligo Patients. Regazzetti, Claire; Joly, Florence; Marty, Carine; Rivier, Michel; Mehul, Bruno; Reiniche, Pascale; Mounier, Carine; Rival, Yves; Piwnica, David; Cavalié, Marine; Chignon-Sicard, Bérengère; Ballotti, Robert; Voegel, Johannes; Passeron, Thierry // Journal of Investigative Dermatology;Dec2015, Vol. 135 Issue 12, p3105 

    Vitiligo affects 1% of the worldwide population. Halting disease progression and repigmenting the lesional skin represent the two faces of therapeutic challenge in vitiligo. We performed transcriptome analysis on lesional, perilesional, and non-depigmented skin from vitiligo patients and on...

  • What are those round white patches? Barankin, Benjamin // Patient Care;Dec2006, Vol. 40 Issue 12, p47 

    The article discusses a case of vitiligo in a teenage boy. Vitiligo is characterized by asymptomatic depigmented areas of the epidermis. It is caused by a condition in which some or all the melanocytes in the interfollicular epidermis are destroyed. Vitiligo can be diagnosed by biopsy and Wood's...

  • A study of autologous melanocyte transfer in treatment of stable vitiligo. Pandya, Vishvabhavan; Parmar, Kirti S.; Shah, Bela J.; Bilimoria, F. E. // Indian Journal of Dermatology, Venereology & Leprology;Nov/Dec2005, Vol. 71 Issue 6, p393 

    Background: Replenishing melanocytes selectively in vitiliginous macules by autologous melanocytes is a promising treatment. With expertise in culturing melanocytes, it has now become possible to treat larger recipient areas with smaller skin samples. Aim: To study the extent of repigmentation...

  • Independent Nurse: Clinical - Dermatology - Diagnosing and treating vitiligo. Gawkrodger, David J. // GP: General Practitioner;1/26/2007, p101 

    The article presents information on the diagnosis and treatment of vitiligo. It informs that this disease is a depigmenting disorder, characterised by sharply defined white macules resulting from the loss of melanocytes from the cutaneous epidermis. It is stated that ointments are used to treat...

  • Melanocyte Destruction and Repigmentation in Vitiligo: A Model for Nerve Cell Damage and Regrowth. Hsin-Su Yu // Journal of Biomedical Science;2002, Vol. 9 Issue 6, p564 

    Melanocytes (MCs) are melanin-producing cells of the skin that are derived from neural crest cells. Vitiligo vulgaris is a common depigmentation disorder resulting from the destruction of functional MCs in the affected skin. The three prevailing pathomechanisms of vitiligo are the immune...

  • ACETYLCHOLINE ESTERASE LEVELS IN DIFFERENT CLINICAL TYPES OF VITILIGO IN BARODA, GUJARAT. Shajil, E. M.; Marfatia, Y. S.; Begum, Rasheedunnisa // Indian Journal of Dermatology;2006, Vol. 51 Issue 4, p289 

    Vitiligo is an acquired depigmentary disorder involving a progressive loss of melanocytes from the epidermis and hair follicles. Gujarat has a high prevalence of vitiligo. One of the major hypotheses in the pathogenesis of vitiligo is the neurochemical hypothesis. According to the neural...

  • OXIDATIVE STRESS LEVEL AND TYROSINASE ACTIVITY IN VITILIGO PATIENTS. Eskandani, M.; Golchai, J.; Pirooznia, N.; Hasannia, S. // Indian Journal of Dermatology;Jan-Mar2010, Vol. 55 Issue 1, p15 

    Background: Vitiligo is an acquired pigmentary disorder of the skin. Genetic factors, oxidative stress, autoimmunity, and neurochemical agents might be contributing factors for the development of the disease. Aims: To evaluate the oxidative stress level and tyrosinase activity in vitiligo...

  • Melanocyte Regeneration in Vitiligo Requires WNT beneath their Wings. Harris, John E // Journal of Investigative Dermatology;Dec2015, Vol. 135 Issue 12, p2921 

    Melanocytes in patients with vitiligo possess intrinsic abnormalities that contribute to its pathogenesis. Regazzetti et al. report that CXCL10 expression reflects subtle inflammation in normal-appearing skin but not in stable depigmented lesions, supporting the hypothesis that melanocytes...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics